You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Selected Demographic and Baseline Characteristics

From: The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study

  DIG(N = 265) EIG(N = 179) P value
Age: years (IQR) 33(27–42) 32(27–40) 0.276
Male: no. (%) 199(75.1) 125 (69.8) 0.232
Ethnicity:no. (%)
 Han 195(73.6) 123(68.1) 0.284
 Other 70 (26.4) 56 (31.9)  
Mode of HIV acquisition: no. (%)
 MSM 92 (34.7%) 63 (35.2%) 0.920
  Heterosexual 142 (53.6%) 98 (54.7%) 0.846
  Bisexual 6 (2.3%) 6 (3.4%) 0.557
  Blood products 2 (0.4%) 1 (0.6%) 1.000
  Other/undefined 14 (9.3%) 11 (5.5%) 0.682
HIV-1 subtype
 AE 125 (47.2%) 60 (33.5%) 0.004
 B/C/BC 69 (26.0%) 63 (35.2%) 0.044
  unknown 71 (26.8%) 56 (31.3%) 0.336
CD4 count: (cells/mm3) 239 (161–292) 401 (376–451) < 0.001
CD4/CD8 ratio: 0.25 (0.19–0.39) 0.39 (0.24–0.45) 0.001
HIV-1 RNA: (log10 copies/mL) 4.83 (4.43–5.14) 4.66 (4.39–5.05) 0.641
HIV-1 DNA: (log10 copies /106PBMCs) 3.00 (2.65–3.39) 2.73 (2.40–3.03) < 0.001
HBsAg (+): no. (%) 27 (10.2%) 18 (10.1%) 1.000
HCV-Ab (+): no. (%) 9 (3.4%) 4 (2.2%) 0.579
  1. Data are number (%) or median (IQR). MSM: men who have sex with men; DIG: delayed initiation group; EIG: early initiation group; HIV: human immunodeficiency virus; IQR: interquartile range; PBMC: peripheral mononuclear cell; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; Ab: antibody